2014-05-27 Just look, but don’t touch: EMA terms of use for clinical study data are impracticable Data are only allowed to be viewed on screen / Pre-censorship by drug manufacturers The European Medicines Agency (EMA) receives comprehensive clinical study data from drug manufacturers. These data form the basis for the decision on the approval of new drugs. To make this information available to researchers and decision-makers, EMA issued a draft policy in 2013 for the publication of clinical study data, in which extensive data transparency was planned. Besides other interested parties, the German Institute for More…![]()
